Preoperative increased systemic immune-inflammation index predicts poor prognosis in patients with operable non-small cell lung cancer
ConclusionsPreoperative SII was a powerful prognostic biomarker for predicting outcome in patients with operable NSCLC. Preoperative SII may assist clinicians treatment strategy making and individual treatment choice.
Source: Clinica Chimica Acta - Category: Laboratory Medicine Source Type: research
More News: Cancer | Cancer & Oncology | Carcinoma | Lung Cancer | Non-Small Cell Lung Cancer | Study